Ten Stocks Trending on Discord for Friday November 18, 2022: ARDX, PRVB, TSLA, AGBA, ROST, DLO, AMAT, GLBL, STNE, PANW
$AGBA
$AMAT
$ARDX
$DLO
Investment Managers
Finance
Semiconductors
Technology
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 3/5/2026 | Hold | Erste Group | ||
| 3/4/2026 | $460.00 | Buy | BofA Securities | |
| 3/4/2026 | $220.00 → $240.00 | Market Perform → Outperform | Telsey Advisory Group | |
| 3/3/2026 | $185.00 | Sell → Buy | Arete | |
| 2/25/2026 | $175.00 → $220.00 | Market Perform | Telsey Advisory Group | |
| 2/18/2026 | $230.00 → $200.00 | Outperform | BMO Capital Markets | |
| 2/13/2026 | $450.00 | Hold → Buy | Craig Hallum | |
| 2/13/2026 | Hold → Buy | Summit Insights |
4 - ARDELYX, INC. (0001437402) (Issuer)
4 - Tesla, Inc. (0001318605) (Issuer)
4 - ARDELYX, INC. (0001437402) (Issuer)
Erste Group initiated coverage of Applied Materials with a rating of Hold
BofA Securities resumed coverage of Tesla with a rating of Buy and set a new price target of $460.00
Telsey Advisory Group upgraded Ross Stores from Market Perform to Outperform and set a new price target of $240.00 from $220.00 previously
Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated
Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling
Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling
3 - dLocal Ltd (0001846832) (Issuer)
4 - ROSS STORES, INC. (0000745732) (Issuer)
4 - ARDELYX, INC. (0001437402) (Issuer)
4Q25: Ending the year with strong growth momentum, with broad-based acceleration across key metrics. TPV at an all-time quarterly high of US$13.1 billion, growing 70% year-over-year, the fifth straight quarter above 50% year-over-year. Revenue up +65% year-over-year reaching US$338 million for the quarter. Gross profit reached US$116 million, up +38% year-over-year. Adjusted EBITDA up +38% year-over-year, representing 68% of gross profit, underscoring best-in-class operating leverage and disciplined cost management. Net income growth at +87% year-over-year. Solid free cash generation, with adjusted free cash flow to net income ratio at 117%. 2025: Demonstrated the scale of the emerging ma
SANTA CLARA, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that its Board of Directors has approved a 15-percent increase in the quarterly cash dividend, from $0.46 to $0.53 per share, payable on June 11, 2026 to shareholders of record as of May 21, 2026. This marks nine consecutive years of dividend increases. "With the increase announced today, Applied Materials has more than doubled its dividend per share from four years ago," said Brice Hill, Senior Vice President and CFO. "This demonstrates our ability to generate strong cash flow and attractive shareholder distributions while investing to enable profitable growth." The cash dividend is a key com
WALTHAM, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, announced the recipients of the 2026 Derek Forfang Patient Advocate Award: Edward Drake II, Markesha Grayson, Timmy Nelson, Pesh Patel and Glenda Roberts. Established in 2025, this award honors Derek Forfang, a passionate patient advocate who suffered from chronic kidney disease (CKD) and passed away due to issues related to his disease in 2023. Derek worked tirelessly to improve the lives of patients, families and caregivers in the CKD community. Cand
4Q25: Ending the year with strong growth momentum, with broad-based acceleration across key metrics. TPV at an all-time quarterly high of US$13.1 billion, growing 70% year-over-year, the fifth straight quarter above 50% year-over-year. Revenue up +65% year-over-year reaching US$338 million for the quarter. Gross profit reached US$116 million, up +38% year-over-year. Adjusted EBITDA up +38% year-over-year, representing 68% of gross profit, underscoring best-in-class operating leverage and disciplined cost management. Net income growth at +87% year-over-year. Solid free cash generation, with adjusted free cash flow to net income ratio at 117%. 2025: Demonstrated the scale of the emerging ma
SANTA CLARA, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that its Board of Directors has approved a 15-percent increase in the quarterly cash dividend, from $0.46 to $0.53 per share, payable on June 11, 2026 to shareholders of record as of May 21, 2026. This marks nine consecutive years of dividend increases. "With the increase announced today, Applied Materials has more than doubled its dividend per share from four years ago," said Brice Hill, Senior Vice President and CFO. "This demonstrates our ability to generate strong cash flow and attractive shareholder distributions while investing to enable profitable growth." The cash dividend is a key com
ANNOUNCES NEW TWO-YEAR REPURCHASE AUTHORIZATION AND 10% INCREASE IN QUARTERLY CASH DIVIDENDPROVIDES FIRST QUARTER AND FISCAL 2026 GUIDANCEDUBLIN, Calif., March 3, 2026 /PRNewswire/ -- Ross Stores, Inc. (NASDAQ:ROST) today reported financial results for the 13‑week fourth quarter and 52‑week fiscal year ended January 31, 2026. Highlights:Total sales for the fourth quarter of fiscal 2025 grew 12%, with comparable store sales increasing a robust 9%Fourth quarter operating margin of 12.3% exceeded the Company's plan of 11.5% to 11.8%, primarily from the strong sales performanceEarnings per share for the fourth quarter of $2.00 was well above guidance of $1.77 to $1.85For the full year, sales rea
NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M
George Town, Grand Cayman--(Newsfile Corp. - January 7, 2026) - StoneCo Ltd. (NASDAQ:STNE) ("Stone" or "the Company") announces today that Mr. Pedro Zinner has informed the Board of Directors of his decision to resign from his position as Chief Executive Officer, effective March 2026, for personal reasons.Mr. Zinner assumed the role of CEO three years ago, following his service on the Company's Board, at a critical moment in Stone's trajectory. During his tenure, Stone executed a clear strategic pivot, including the divestment of non-core assets such as Linx, the implementation of broad streamlining initiatives, the establishment of a disciplined capital allocation framework, and meaningful
MONTEVIDEO, Uruguay, Dec. 23, 2025 (GLOBE NEWSWIRE) -- dLocal Limited ("dLocal", the "company", "we", "us", and "our") (NASDAQ:DLO), a leading financial technology company powering payments across emerging markets, today announced it has completed the transition to a nine-person, majority independent Board of Directors, now comprising five independent members. Following through on the governance update shared in August during its second quarter earnings presentation, dLocal has appointed Paco Ybarra and Nelson Mattos as independent directors, further strengthening the Board's depth in global technology, financial markets, and risk management. Mr. Ybarra joins the Board after a 36‑year ca
SC 13G/A - ARDELYX, INC. (0001437402) (Subject)
SC 13G/A - ROSS STORES, INC. (0000745732) (Subject)
SC 13G/A - dLocal Ltd (0001846832) (Subject)